1. Adriamycin — a new anticancer drug with significant clinical activity;Blum;Ann. Intern. Med.,1974
2. Antitumor activity in a series of bis-diketopiperazines;Creighton;Nature,1969
3. Experimental animal models of adriamycin cardiotoxicity;Dorochow;Cancer Treat. Rep.,1979
4. Studies in mice with ICRF 159 combined with daunorubicin and doxorubicin;Giuliani;Cancer Treat. Rep.,1981
5. Reduction of chronic doxorubicin cardiotoxicity in dogs by pretreatment with (±)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187);Herman;Cancer Res.,1981